Zevia PBC (NYSE:ZVIA) Price Target Cut to $5.00 by Analysts at Telsey Advisory Group

Zevia PBC (NYSE:ZVIA) had its target price decreased by Telsey Advisory Group from $6.00 to $5.00 in a report issued on Thursday morning, Marketbeat Ratings reports. Telsey Advisory Group currently has an outperform rating on the stock.

Several other equities research analysts have also commented on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Zevia PBC in a research report on Wednesday, January 21st. Zacks Research cut shares of Zevia PBC from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 5th. Finally, Craig Hallum assumed coverage on shares of Zevia PBC in a research report on Thursday, January 15th. They set a “buy” rating and a $4.00 price objective for the company. Three analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $4.43.

Zevia PBC Stock Down 12.3%

ZVIA opened at $1.36 on Thursday. The stock has a market capitalization of $102 million, a price-to-earnings ratio of -9.07 and a beta of 0.86. The firm has a 50 day moving average price of $1.89 and a 200-day moving average price of $2.34. Zevia PBC has a twelve month low of $1.11 and a twelve month high of $3.66.

Zevia PBC (NYSE:ZVIA) last announced its earnings results on Wednesday, February 25th. The company reported ($0.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.01. The business had revenue of $37.87 million during the quarter, compared to analyst estimates of $39.96 million. Zevia PBC had a negative net margin of 6.15% and a negative return on equity of 22.29%. As a group, analysts expect that Zevia PBC will post -0.32 earnings per share for the current year.

Insider Buying and Selling

In other Zevia PBC news, major shareholder De Depot Et Placement D. Caisse sold 3,500,000 shares of the firm’s stock in a transaction dated Tuesday, January 27th. The stock was sold at an average price of $2.00, for a total transaction of $7,000,000.00. Following the sale, the insider directly owned 13,550,428 shares of the company’s stock, valued at $27,100,856. This trade represents a 20.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 11.11% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Police & Firemen s Retirement System of New Jersey purchased a new stake in Zevia PBC during the 2nd quarter valued at approximately $25,000. TD Waterhouse Canada Inc. lifted its stake in Zevia PBC by 6.7% in the 4th quarter. TD Waterhouse Canada Inc. now owns 131,042 shares of the company’s stock worth $303,000 after purchasing an additional 8,237 shares in the last quarter. CreativeOne Wealth LLC boosted its holdings in shares of Zevia PBC by 45.4% during the 3rd quarter. CreativeOne Wealth LLC now owns 28,162 shares of the company’s stock valued at $77,000 after purchasing an additional 8,787 shares during the last quarter. Quadrature Capital Ltd bought a new position in shares of Zevia PBC during the 4th quarter valued at about $26,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in shares of Zevia PBC during the fourth quarter valued at about $27,000. 53.21% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Zevia PBC

Here are the key news stories impacting Zevia PBC this week:

• Positive Sentiment: Q4 EPS beat consensus (reported -$0.02 vs. -$0.03 estimate), signaling some margin progress despite challenges. Zevia Announces Fourth Quarter and Full Year 2025 Results; Appoints Lead Independent Director, Andrew Ruben, to Chair of the Board
• Positive Sentiment: Management projects roughly 6% net sales growth for 2026 and highlights progress on national distribution and product innovation, which supports medium-term revenue expansion if execution continues. Zevia projects 6% net sales growth for 2026 while advancing national distribution and product innovation
• Positive Sentiment: Telsey Advisory lowered its price target from $6 to $5 but kept an “outperform” rating, indicating some analyst conviction in recovery upside despite trimming forecasts. Benzinga
• Neutral Sentiment: Board leadership change: the company appointed lead independent director Andrew Ruben as board chair — a governance update that may be viewed neutrally or slightly positive by investors. Zevia Announces Fourth Quarter and Full Year 2025 Results; Appoints Lead Independent Director, Andrew Ruben, to Chair of the Board
• Neutral Sentiment: Full Q4 earnings call/transcript details management’s plan to navigate supply/route-to-market headwinds; useful for investors but currently more informational than catalytic. Zevia PBC (ZVIA) Q4 2025 Earnings Call Transcript
• Negative Sentiment: Q4 revenue missed expectations ($37.87M vs. consensus ~$39.96M), a direct top-line shortfall that likely triggered near-term selling pressure. Zevia PBC earnings report and call
• Negative Sentiment: FY2026 revenue guidance of $169.0M–$173.0M is slightly below consensus (~$173.6M); Q1 revenue guidance $40.0M–$42.0M versus ~$40.7M estimate — the cautious ranges amplify concerns about near-term growth momentum. Zevia Announces Fourth Quarter and Full Year 2025 Results; Appoints Lead Independent Director, Andrew Ruben, to Chair of the Board

About Zevia PBC

Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia’s mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.

The company’s product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.